EP3138916 - Bibliographic data
COMPOSITION IMMUNOGÈNE
| Last update | 22/07/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Européen |
| (73) Holder |
GlaxoSmithKline Biologicals S.A. Rue de l'Institut, 89
1330 Rixensart
Belgique
|
|---|---|
| (72) Inventors |
Cindy CASTADO GlaxoSmithKline Biologicals s.a.
Rue de l'Institut 89
1330 Rixensart
Belgique
|
| (74) Agent |
Mail recipient Johnston, Caroline Louise et al GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS
Royaume-Uni
|
| (21) Request number | EP16193340.3 |
|---|---|
| (22) Request date | 25/05/2012 |
| (11) Publication number | EP3138916 |
|---|---|
| Publication date | 19/06/2019 |
| (54) Title of the invention | COMPOSITION IMMUNOGÈNE |
|---|---|
| (51) International classification | C12N 15/62, C07K 14/33, A61K 39/08 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 201161490707 P |
|---|---|
| Initial application | None |
| Divisional application | EP19179871.9 /EP3564378 None |
| Expected annuity |
Annuity: 9 -
Amount: 150 € -
Due date 02/06/2020
Surtax: 9 - Amount: 30 € - Due date 03/12/2020 |
|---|---|
| Last annuity | None |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 19/06/2019 Entrée en période de grâce du brevet d'invention - Legal date 03/06/2020 Déchéance du brevet d'invention après période de grâce - Legal date 02/06/2020 Révocation du brevet européen - Legal date 24/10/2023 |